drugset / Trial / NCT01460212

Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder

NCT01460212 ↗

Phase 4 Unknown 80 enrolled Nanjing Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

Study hypothesis: psychotherapy and SSRI treatment effect in different brain way: psychotherapy in "up to down" way and SSRI in "down to up" way. The investigators will explore this hypothesis in major depressive disorder outpatients with Magnetic Resonance Imaging analysis in this study. Patients in different groups will be treated by psychotherapy or SSRI treatment. They will all be checked with Magnetic Resonance Imaging pro and after 12 weeks of treatment.

Timeline

Start
2011-12
Primary completion
2014-12
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Citalopram Small molecule — —
Comparator Escitalopram Small molecule — —
Comparator Fluoxetine Small molecule — —
Comparator Fluvoxamine Unknown — —
Comparator Paroxetine Small molecule — —
Comparator Sertraline Small molecule — —